626 related articles for article (PubMed ID: 8923589)
1. Pathogenesis of scleroderma. Collagen.
Jimenez SA; Hitraya E; Varga J
Rheum Dis Clin North Am; 1996 Nov; 22(4):647-74. PubMed ID: 8923589
[TBL] [Abstract][Full Text] [Related]
2. Regulation of connective tissue synthesis in systemic sclerosis.
Varga J; Bashey RI
Int Rev Immunol; 1995; 12(2-4):187-99. PubMed ID: 7650421
[TBL] [Abstract][Full Text] [Related]
3. Basic fibroblast growth factor inhibits basal and transforming growth factor-beta induced collagen alpha 2(I) gene expression in scleroderma and normal fibroblasts.
Ichiki Y; Smith EA; LeRoy EC; Trojanowska M
J Rheumatol; 1997 Jan; 24(1):90-5. PubMed ID: 9002017
[TBL] [Abstract][Full Text] [Related]
4. Alterations in the regulation of expression of the alpha 1(I) collagen gene (COL1A1) in systemic sclerosis (scleroderma).
Jimenez SA; Saitta B
Springer Semin Immunopathol; 1999; 21(4):397-414. PubMed ID: 10945033
[TBL] [Abstract][Full Text] [Related]
5. Impaired IL-17 signaling pathway contributes to the increased collagen expression in scleroderma fibroblasts.
Nakashima T; Jinnin M; Yamane K; Honda N; Kajihara I; Makino T; Masuguchi S; Fukushima S; Okamoto Y; Hasegawa M; Fujimoto M; Ihn H
J Immunol; 2012 Apr; 188(8):3573-83. PubMed ID: 22403442
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of skin fibrosis in systemic sclerosis.
Jinnin M
J Dermatol; 2010 Jan; 37(1):11-25. PubMed ID: 20175837
[TBL] [Abstract][Full Text] [Related]
7. Tumor necrosis factor alpha suppresses the induction of connective tissue growth factor by transforming growth factor-beta in normal and scleroderma fibroblasts.
Abraham DJ; Shiwen X; Black CM; Sa S; Xu Y; Leask A
J Biol Chem; 2000 May; 275(20):15220-5. PubMed ID: 10809757
[TBL] [Abstract][Full Text] [Related]
8. Connective tissue growth factor causes persistent proalpha2(I) collagen gene expression induced by transforming growth factor-beta in a mouse fibrosis model.
Chujo S; Shirasaki F; Kawara S; Inagaki Y; Kinbara T; Inaoki M; Takigawa M; Takehara K
J Cell Physiol; 2005 May; 203(2):447-56. PubMed ID: 15605379
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of hepatocyte growth factor receptor in scleroderma dermal fibroblasts is caused by autocrine transforming growth factor β signaling.
Kajihara I; Jinnin M; Makino T; Masuguchi S; Sakai K; Fukushima S; Maruo K; Inoue Y; Ihn H
Biosci Trends; 2012 Jun; 6(3):136-42. PubMed ID: 22890162
[TBL] [Abstract][Full Text] [Related]
10. Autocrine TGF-beta signaling in the pathogenesis of systemic sclerosis.
Ihn H
J Dermatol Sci; 2008 Feb; 49(2):103-13. PubMed ID: 17628443
[TBL] [Abstract][Full Text] [Related]
11. Scleroderma keratinocytes promote fibroblast activation independent of transforming growth factor beta.
McCoy SS; Reed TJ; Berthier CC; Tsou PS; Liu J; Gudjonsson JE; Khanna D; Kahlenberg JM
Rheumatology (Oxford); 2017 Nov; 56(11):1970-1981. PubMed ID: 28968684
[TBL] [Abstract][Full Text] [Related]
12. Sirt1 regulates canonical TGF-β signalling to control fibroblast activation and tissue fibrosis.
Zerr P; Palumbo-Zerr K; Huang J; Tomcik M; Sumova B; Distler O; Schett G; Distler JH
Ann Rheum Dis; 2016 Jan; 75(1):226-33. PubMed ID: 25180292
[TBL] [Abstract][Full Text] [Related]
13. Cytokines and human fibrosis.
LeRoy EC; Trojanowska MI; Smith EA
Eur Cytokine Netw; 1990; 1(4):215-9. PubMed ID: 1966552
[TBL] [Abstract][Full Text] [Related]
14. Collagen type I is not under autocrine control by transforming growth factor-beta 1 in normal and scleroderma fibroblasts.
McWhirter A; Colosetti P; Rubin K; Miyazono K; Black C
Lab Invest; 1994 Dec; 71(6):885-94. PubMed ID: 7807970
[TBL] [Abstract][Full Text] [Related]
15. Oxidative stress in scleroderma: maintenance of scleroderma fibroblast phenotype by the constitutive up-regulation of reactive oxygen species generation through the NADPH oxidase complex pathway.
Sambo P; Baroni SS; Luchetti M; Paroncini P; Dusi S; Orlandini G; Gabrielli A
Arthritis Rheum; 2001 Nov; 44(11):2653-64. PubMed ID: 11710721
[TBL] [Abstract][Full Text] [Related]
16. Disruption of transforming growth factor beta signaling and profibrotic responses in normal skin fibroblasts by peroxisome proliferator-activated receptor gamma.
Ghosh AK; Bhattacharyya S; Lakos G; Chen SJ; Mori Y; Varga J
Arthritis Rheum; 2004 Apr; 50(4):1305-18. PubMed ID: 15077315
[TBL] [Abstract][Full Text] [Related]
17. CD109, a TGF-β co-receptor, attenuates extracellular matrix production in scleroderma skin fibroblasts.
Man XY; Finnson KW; Baron M; Philip A
Arthritis Res Ther; 2012 Jun; 14(3):R144. PubMed ID: 22694813
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-beta promotes deposition of collagen VII in a modified organotypic skin model.
König A; Bruckner-Tuderman L
Lab Invest; 1994 Feb; 70(2):203-9. PubMed ID: 8139261
[TBL] [Abstract][Full Text] [Related]
19. Tribbles homologue 3 stimulates canonical TGF-β signalling to regulate fibroblast activation and tissue fibrosis.
Tomcik M; Palumbo-Zerr K; Zerr P; Sumova B; Avouac J; Dees C; Distler A; Becvar R; Distler O; Schett G; Senolt L; Distler JH
Ann Rheum Dis; 2016 Mar; 75(3):609-16. PubMed ID: 25603829
[TBL] [Abstract][Full Text] [Related]
20. Elevated Fibronectin Levels in Profibrotic CD14
Rudnik M; Hukara A; Kocherova I; Jordan S; Schniering J; Milleret V; Ehrbar M; Klingel K; Feghali-Bostwick C; Distler O; Błyszczuk P; Kania G
Front Immunol; 2021; 12():642891. PubMed ID: 34504485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]